Assertio Holdings, Inc. Common Stock earnings per share and revenue
On Nov 10, 2025, ASRT reported earnings of 1.80 USD per share (EPS) for Q3 25, beating the estimate of -1.30 USD, resulting in a 238.41% surprise. Revenue reached 49.46 million, compared to an expected 27.56 million, with a 79.46% difference. The market reacted with a +14.89% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 6 analysts forecast an EPS of -2.75 USD, with revenue projected to reach 16.96 million USD, implying an decrease of -252.78% EPS, and decrease of -65.71% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Citius Pharmaceuticals Inc. Common
Report Date
Dec 26, 2025 For Q4 25
Estimate
-$0.49
Actual
-
Surprise
-
FAQ
What were Assertio Holdings, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Assertio Holdings, Inc. Common Stock reported EPS of $1.80, beating estimates by 238.41%, and revenue of $49.46M, 79.46% above expectations.
How did the market react to Assertio Holdings, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 14.89%, changed from $12.02 before the earnings release to $13.80 the day after.
When is Assertio Holdings, Inc. Common Stock expected to report next?
The next earning report is scheduled for Mar 10, 2026.
What are the forecasts for Assertio Holdings, Inc. Common Stock's next earnings report?
Based on 6
analysts, Assertio Holdings, Inc. Common Stock is expected to report EPS of -$2.75 and revenue of $16.96M for Q4 2025.